NCT06466889Recruiting
Mastocytosis Registry (of Zurich)
Summary
The study aims to summarize patients with mastocytosis and hypertryptasämia (without underlying mastocytosis or no bone marrow biopsy) in relation to demographic information, clinical progress and treatment courses. Biologic samples are collected from available routine diagnostics (serum, skin tissue, gut mucosa, bone marrow, and others) for further use in experimental research.
Inclusion criteria
• Adult patients with mastocytsis/hypertryptasemia which are treated at the university hospital of Zurich • available informed consent
Exclusion criteria
• denied consent
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Countries
- Switzerland
- Sponsor
- University of Zurich(Other)
- Protocol no.
- BASEC 2020-01568
- Conditions
- Mastocytosis, Hypertryptasemia
- Interventions
- —
Locations · 1
- Zurich, SwitzerlandUniversity Hospital of ZurichRecruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: June 26, 2024).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.